What it sells
Builds a world model of the human brain: grows standardized human brain organoids, reads them repeatedly (imaging, functional activity, molecular) and trains predictive models on the data for neurodevelopment, neurodegeneration and brain longevity.
Business model breakdown
Workflow: what inputs become what output?
Custom studies designed around the customer program, run on Vale organoids; customer receives full dataset, experimental documentation and analysis-ready outputs.
Distribution: how it reaches customers
Talk to the team (contact); custom studies available now, predictive models from 2027.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-11-09 | — | CHF 150K | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-11-10.